Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial
type: MedicalStudy
description: Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2020-08-15
end date: 2021-02-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT04678739
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: M Abdur Rahim Medical College and Hospital
study subject: Covid19
study subject: Covid-19 ARDS
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Covid19
keywords: Covid-19 ARDS

AI Analytics
type: Organization